Multi-omics Insights into PDHA1 as a Predictive Biomarker for Prognosis, Immunotherapy Efficacy, and Drug Sensitivity in Hepatocellular Carcinoma

• Yong Pan,
• Yiru Zhang,
• Daiwen Mao,
• Zhou Fang,
• Yingqiu Ma,
• Danwen Jin,
• Shibo Li

Affiliations

Yong Pan

Department of Infectious Diseases, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, China

Yiru Zhang

State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Hangzhou, China

Daiwen Mao

Department of Infectious Diseases, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, China

Zhou Fang

Department of Infectious Diseases, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, China

Yingqiu Ma

Department of Infectious Diseases, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, China

Danwen Jin

Pathological Diagnosis Center, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, China

Shibo Li

Department of Infectious Diseases, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, China